+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Weight Loss and Obesity Management Market

  • ID: 5387790
  • Report
  • June 2021
  • Region: Global
  • 243 pages
  • Qualiket Research

FEATURED COMPANIES

  • Cybex International
  • Eisai Co. Ltd.
  • etc
  • Ethicon Inc.
  • F. Hoffmann-La Roche Ltd
  • Herbalife Ltd.
Obesity is defined as a chronic medical condition characterized by excessive accumulation and storage of fats in body. It is measured by Body Mass Index (BMI). Various methods used for management of weight loss & obesity are drugs, dietary supplements, weight loss surgery, and exercising. As per the World Health Organization (WHO) information, when the Body-Mass-Index is greater than/equal to 25, the person is categorized as overweight and Body Mass Index (BMI) above 30 is classified as obese.

Market Drivers

The increase in disposable income, the growing intake of fast-food with high calories as well as the increase in the acceptance of unhealthy lifestyle due to the increase in growth in the fast-food industry are the key driving factors leading to obesity. Thus, there is a high demand for weight loss and obesity management further supporting the growth of the market. Furthermore, the initiatives taken by the government and profit/non-profit enterprises to take action at local, regional, and global levels to improve physical activity & diet patterns in the population is also fueling the growth of the global weight loss and obesity management market growth.

Moreover, the increase in outbreak of COVID-19 almost 88% of the companies have encouraged their employees to work from home, owing to this, there has been a considerable decline in the physical activity of the people results weight gain & related problems which expected to propel the growth of global weight loss and obesity management market growth over the forecast period.

Market Restraints

Product recall is the major restraint which expected to hamper the global weight loss and obesity management market growth. For instance, in May 2021, Food and Drug Administration has recalled over-the-counter weight loss drug Lipodrene w/25mg Ephedra Extract Dietary Supplement due to the presence of an illegal ingredient (DMAA) which can cause serious problems like shortness of breath, elevated blood pressure, arrhythmias, and heart attack.

Market Segmentation

The Global Weight Loss and Obesity Management Market is segmented into diet such as Meals, Beverages, and Supplements. Diet is gaining popularity for weigh loss management in developed and in developing countries. Meals comprises the good amount of fibers, proteins, and lesser amount of carbohydrates are considered as an effective weight management method. Further, market is segmented into Fitness Equipment, and Surgical Equipment. The Fitness equipment is expected to hold largest share of the market. On the basis of services market is segmented into Fitness Centers, Sliming centers, Consultation services, and Online weight loss services.

Regional Analysis

The Global Weight Loss and Obesity Management Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.

The North America region accounts for the largest market share in 2020 due to the increase in population of overweight as well as the increase in incidence of hypertension and diabetes. The APAC region is anticipated to account for the fastest growth over the forecast period. Due to the increase in awareness of available alternatives for weight loss and management, the increase in popularity of diet plans will significantly drive the global weight loss and obesity management market growth.

Key Players

Some of the key players competing in this industry such as Novo Nordisk A/S, Herbalife Ltd., Takeda Pharmaceutical, F. Hoffmann-La Roche Ltd, Eisai Co., Ltd., NutriSystem, Inc., Cybex International, Ethicon Inc., Johnson & Johnson Services, Inc, Medtronic,etc. The growing adoption of strategies by key players is expected to support the growth of global weight loss and obesity management market. For instance, in, May 2021, according to the study results from a Phase IIIa study have demonstrated that Novo Nordisk’s weight loss drug semaglutide can improve physical function and wellbeing among people with obesity.

Market Taxonomy

By Diet
  • Meals
  • Beverages
  • Supplements
By Equipment
  • Fitness Equipment
  • Surgical Equipment
By Services
  • Fitness Centers
  • Sliming centers
  • Consultation services
  • Online weight loss services
By Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa
Key Questions Addressed by the Report
  • What are the Key Opportunities in Global Weight Loss and Obesity Management Market?
  • What will be the growth rate from 2019 to 2027?
  • Which segment/region will have highest growth?
  • What are the factors that will impact/drive the Market?
  • What is the competitive Landscape in the Industry?
  • What is the role of key players in the value chain?
  • What are the strategies adopted by key players?
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Cybex International
  • Eisai Co. Ltd.
  • etc
  • Ethicon Inc.
  • F. Hoffmann-La Roche Ltd
  • Herbalife Ltd.
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope

2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources

3 Executive Summary

4 Global Weight Loss and Obesity Management Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 Global Weight Loss and Obesity Management Market, By Diet
5.1 Y-o-Y Growth Comparison, By Diet
5.2 Global Weight Loss and Obesity Management Market Share Analysis, By Diet
5.3 Global Weight Loss and Obesity Management Market Size and Forecast, By Diet
5.3.1 Meals
5.3.2. Beverages
5.3.3. Supplements

6 Global Weight Loss and Obesity Management Market, By Equipment
6.1 Y-o-Y Growth Comparison, By Equipment
6.2 Global Weight Loss and Obesity Management Market Share Analysis, By Equipment
6.3 Global Weight Loss and Obesity Management Market Size and Forecast, By Equipment
6.3.1 Fitness Equipment
6.3.2 Surgical Equipment

7 Global Weight Loss and Obesity Management Market, By Services
7.1 Y-o-Y Growth Comparison, By Services
7.2 Global Weight Loss and Obesity Management Market Share Analysis, By Services
7.3 Global Weight Loss and Obesity Management Market Size and Forecast, By Services
7.3.1 Fitness Centers
7.3.2. Sliming centers
7.3.3. Consultation services
7.3.4. Online weight loss services

8 Global Weight Loss and Obesity Management Market, By Region
8.1 Global Weight Loss and Obesity Management Market Share Analysis, By Region
8.2 Global Weight Loss and Obesity Management Market Share Analysis, By Region
8.3 Global Weight Loss and Obesity Management Market Size and Forecast, By Region

9 North America Weight Loss and Obesity Management Market Analysis and Forecast (2020-2027)
9.1 Introduction
9.2 North America Weight Loss and Obesity Management Market Share Analysis, By Diet
9.3 North America Weight Loss and Obesity Management Market Size and Forecast, By Equipment
9.4 North America Weight Loss and Obesity Management Market Size and Forecast, By Services
9.5 North America Weight Loss and Obesity Management Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico

10 EuropeWeight Loss and Obesity Management Market Analysis and Forecast (2020-2027)
10.1 Introduction
10.2 Europe Weight Loss and Obesity Management Market Share Analysis, By Diet
10.3 Europe Weight Loss and Obesity Management Market Size and Forecast, By Equipment
10.4 Europe Weight Loss and Obesity Management Market Size and Forecast, By Services
10.5 Europe Weight Loss and Obesity Management Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.5.4 Rest of Europe

11 Asia Pacific Weight Loss and Obesity Management Market Analysis and Forecast (2020-2027)
11.1 Introduction
11.2 Asia Pacific Weight Loss and Obesity Management Market Share Analysis, By Diet
11.3 Asia Pacific Weight Loss and Obesity Management Market Size and Forecast, By Equipment
11.4 Asia Pacific Weight Loss and Obesity Management Market Size and Forecast, By Services
11.5 Asia Pacific Weight Loss and Obesity Management Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4 Rest of Asia Pacific

12 Latin America Weight Loss and Obesity Management Market Analysis and Forecast (2020-2027)
12.1 Introduction
12.2 Latin America Weight Loss and Obesity Management Market Share Analysis, By Diet
12.3 Latin America Weight Loss and Obesity Management Market Size and Forecast, By Equipment
12.4 Latin America Weight Loss and Obesity Management Market Size and Forecast, By Services
12.5 Latin America Weight Loss and Obesity Management Market Size and Forecast, Country

13 Middle East Weight Loss and Obesity Management Market Analysis and Forecast (2020-2027)
13.1 Introduction
13.2 Middle East Weight Loss and Obesity Management Market Share Analysis, By Diet
13.3 Middle East Weight Loss and Obesity Management Market Size and Forecast, By Equipment
13.4 Middle East Weight Loss and Obesity Management Market Size and Forecast, By Services
13.5 Middle East Weight Loss and Obesity Management Market Size and Forecast, By Country

14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies

15 Company Profiles
15.1 Novo Nordisk A/S
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Herbalife Ltd
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Takeda Pharmaceutical
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 F. Hoffmann-La Roche Ltd
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Eisai Co., Ltd
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 NutriSystem, Inc
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 Cybex International
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 Ethicon Inc
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9 Johnson & Johnson Services, Inc
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
15.10 Medtronic
15.10.1 Overview
15.10.2 Offerings
15.10.3 Key Financials
15.10.4 Business Segment & Geographic Overview
15.10.5 Key Market Developments
15.10.6 Key Strategies
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Novo Nordisk A/S
  • Herbalife Ltd.
  • Takeda Pharmaceutical
  • F. Hoffmann-La Roche Ltd
  • Eisai Co. Ltd.
  • NutriSystem Inc.
  • Cybex International
  • Ethicon Inc.
  • Johnson & Johnson Services Inc
  • Medtronic
  • etc
Note: Product cover images may vary from those shown
Adroll
adroll